Login / Signup

Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.

Ruanne V BarnabasElizabeth BrownAnna BershteynR Scott MillerMark WenerConnie CelumAnna WaldHelen ChuDavid WescheJared M Baetennull null
Published in: Trials (2020)
ClinicalTrials.gov, Protocol Registry Number: NCT04328961 Date of registration: April 1, 2020, retrospectively registered FULL PROTOCOL: The full protocol is attached as an additional file, accessible from the Trials website (Additional file 1). In the interest in expediting dissemination of this material, the familiar formatting has been eliminated; this Letter serves as a summary of the key elements of the full protocol.
Keyphrases
  • respiratory syndrome coronavirus
  • coronavirus disease
  • sars cov
  • randomized controlled trial